MoonLake Immunotherapeutics (MLTX)

MLTX Statistics

Total Valuation

MLTX has a market cap or net worth of $911.44 million. The enterprise value is $600.26 million.

Market Cap	911.44M
Enterprise Value	600.26M

Important Dates

The last earnings date was Wednesday, November 5, 2025, before market open.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

MLTX has 71.37 million shares outstanding. The number of shares has increased by 1.82% in one year.

Current Share Class	71.37M
Shares Outstanding	71.37M
Shares Change (YoY)	+1.82%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	9.89%
Owned by Institutions (%)	31.71%
Float	40.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.59
P/TBV Ratio	3.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.50, with a Debt / Equity ratio of 0.26.

Current Ratio	8.50
Quick Ratio	7.95
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-43.62

Financial Efficiency

Return on equity (ROE) is -54.33% and return on invested capital (ROIC) is -33.09%.

Return on Equity (ROE)	-54.33%
Return on Assets (ROA)	-30.72%
Return on Invested Capital (ROIC)	-33.09%
Return on Capital Employed (ROCE)	-62.63%
Revenue Per Employee	n/a
Profits Per Employee	-$2.10M
Employee Count	100
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, MLTX has paid $404,199 in taxes.

Income Tax	404,199
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.30% in the last 52 weeks. The beta is 1.24, so MLTX's price volatility has been higher than the market average.

Beta (5Y)	1.24
52-Week Price Change	-76.30%
50-Day Moving Average	25.20
200-Day Moving Average	39.75
Relative Strength Index (RSI)	44.10
Average Volume (20 Days)	2,681,764

Short Selling Information

The latest short interest is 4.89 million, so 6.85% of the outstanding shares have been sold short.

Short Interest	4.89M
Short Previous Month	5.77M
Short % of Shares Out	6.85%
Short % of Float	12.10%
Short Ratio (days to cover)	0.48

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-229.20M
Pretax Income	-213.29M
Net Income	-210.50M
EBITDA	-226.97M
EBIT	-229.20M
Earnings Per Share (EPS)	-$3.33

Balance Sheet

The company has $380.48 million in cash and $75.73 million in debt, giving a net cash position of $304.75 million or $4.27 per share.

Cash & Cash Equivalents	380.48M
Total Debt	75.73M
Net Cash	304.75M
Net Cash Per Share	$4.27
Equity (Book Value)	291.19M
Book Value Per Share	4.54
Working Capital	362.85M

Cash Flow

In the last 12 months, operating cash flow was -$185.69 million and capital expenditures -$210,520, giving a free cash flow of -$185.90 million.

Operating Cash Flow	-185.69M
Capital Expenditures	-210,520
Free Cash Flow	-185.90M
FCF Per Share	-$2.60

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MLTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.82%
Shareholder Yield	-1.82%
Earnings Yield	-23.26%
FCF Yield	-20.54%

Analyst Forecast

The average price target for MLTX is $36.78, which is 188.02% higher than the current price. The consensus rating is "Buy".

Price Target	$36.78
Price Target Difference	188.02%
Analyst Consensus	Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-18.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1